Biotherapies in multiple sclerosis: a step toward remyelination and neuroprotection?

  title={Biotherapies in multiple sclerosis: a step toward remyelination and neuroprotection?},
  author={A-L Dubessy and Violetta Zujovic and Caroline Papeix and Bruno Stankoff},
  journal={Revue neurologique},
  volume={170 12},
Multiple sclerosis (MS) is a complex disease of the central nervous system (CNS), characterized by CNS-restricted inflammation with subsequent demyelination and neurodegeneration. Current disease-modifying therapies efficiently reduce relapse rate and new lesions appearance, but still fail to impact the progressive course of the disease. There is a great need for the avenue of new therapies aimed at promoting myelin repair or reducing neurodegeneration that should result in the prevention of… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS